Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
or

AC Immune S.A. (ACIU)

AC Immune S.A. (ACIU)
1.5500 x 5 1.6300 x 1
Post-market by (Cboe BZX)
1.5900 -0.0700 (-4.22%) 04/07/25 [NASDAQ]
1.5500 x 5 1.6300 x 1
Post-market 1.5900 unch (unch) 16:02 ET
Quote Overview for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.5000
Day High
1.6500
Open 1.6000
Previous Close 1.6600 1.6600
Volume 379,547 379,547
Avg Vol 206,187 206,187
Stochastic %K 11.23% 11.23%
Weighted Alpha -62.31 -62.31
5-Day Change -0.2800 (-14.97%) -0.2800 (-14.97%)
52-Week Range 1.5000 - 4.9782 1.5000 - 4.9782
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 166,681
  • Shares Outstanding, K 100,410
  • Annual Sales, $ 31,020 K
  • Annual Income, $ -57,840 K
  • EBIT $ -60 M
  • EBITDA $ -57 M
  • 60-Month Beta 1.49
  • Price/Sales 5.73
  • Price/Cash Flow N/A
  • Price/Book 1.37

Options Overview Details

View History
  • Implied Volatility 428.49% ( +22.47%)
  • Historical Volatility 50.42%
  • IV Percentile 100%
  • IV Rank 100.00%
  • IV High 428.49% on 04/04/25
  • IV Low 27.45% on 08/05/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 100
  • Volume Avg (30-Day) 50
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 1,165
  • Open Int (30-Day) 1,082

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.22
  • Number of Estimates 1
  • High Estimate -0.22
  • Low Estimate -0.22
  • Prior Year -0.21
  • Growth Rate Est. (year over year) -4.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5000 +6.00%
on 04/07/25
Period Open: 2.4100
2.5500 -37.65%
on 03/10/25
-0.8200 (-34.02%)
since 03/07/25
3-Month
1.5000 +6.00%
on 04/07/25
Period Open: 2.9300
2.9200 -45.55%
on 01/08/25
-1.3400 (-45.73%)
since 01/07/25
52-Week
1.5000 +6.00%
on 04/07/25
Period Open: 2.7500
4.9782 -68.06%
on 06/07/24
-1.1600 (-42.18%)
since 04/05/24

Most Recent Stories

More News
New Strong Buy Stocks for January 31st

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:EnerSys (ENS): This energy storage solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing...

ACIU : 1.5900 (-4.22%)
SFIX : 2.92 (+2.64%)
MC : 50.05 (-1.01%)
SOPA : 0.7480 (-1.82%)
AC Immune Reports Positive Interim Safety Data for ACI-24.060 in Down Syndrome Phase 1b/2 ABATE Trial

AC Immune reports positive interim safety data for ACI-24.060 in Down syndrome, showing no serious adverse events noted.Quiver AI SummaryAC Immune SA announced positive interim safety data from its Phase...

ACIU : 1.5900 (-4.22%)
AC Immune: Q3 Earnings Snapshot

AC Immune: Q3 Earnings Snapshot

ACIU : 1.5900 (-4.22%)
AC Immune: Q2 Earnings Snapshot

AC Immune: Q2 Earnings Snapshot

ACIU : 1.5900 (-4.22%)
AC Immune: Q1 Earnings Snapshot

AC Immune: Q1 Earnings Snapshot

ACIU : 1.5900 (-4.22%)
AC Immune: Q3 Earnings Snapshot

AC Immune: Q3 Earnings Snapshot

ACIU : 1.5900 (-4.22%)
AC Immune: Q2 Earnings Snapshot

AC Immune: Q2 Earnings Snapshot

ACIU : 1.5900 (-4.22%)
Why Shares of AC Immune Jumped This Week

The FDA has granted a Fast Track Designation to its Alzheimer's disease vaccine candidate.

ACIU : 1.5900 (-4.22%)
AC Immune: Q1 Earnings Snapshot

AC Immune: Q1 Earnings Snapshot

ACIU : 1.5900 (-4.22%)
Is Ardelyx is A Buy After Slip in Early 2022

Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them

ARDX : 4.45 (-2.20%)
CNCE : 8.37 (+0.12%)
KYKOF : 14.7500 (+8.06%)
SFOSF : 1.9450 (+2.37%)
KHTRF : 4.3900 (+4.03%)
ACIU : 1.5900 (-4.22%)
BMEA : 2.01 (-5.19%)

Business Summary

AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta...

See More

Key Turning Points

3rd Resistance Point 1.9100
2nd Resistance Point 1.8500
1st Resistance Point 1.7550
Last Price 1.5900
1st Support Level 1.6000
2nd Support Level 1.5400
3rd Support Level 1.4450

See More

52-Week High 4.9782
Fibonacci 61.8% 3.6495
Fibonacci 50% 3.2391
Fibonacci 38.2% 2.8287
Last Price 1.5900
52-Week Low 1.5000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades